191 related articles for article (PubMed ID: 21826528)
1. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).
Ason B; Castro-Perez J; Tep S; Stefanni A; Tadin-Strapps M; Roddy T; Hankemeier T; Hubbard B; Sachs AB; Michael Flanagan W; Kuklin NA; Mitnaul LJ
Lipids; 2011 Nov; 46(11):991-1003. PubMed ID: 21826528
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
[TBL] [Abstract][Full Text] [Related]
3. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
Hubbard B; Doege H; Punreddy S; Wu H; Huang X; Kaushik VK; Mozell RL; Byrnes JJ; Stricker-Krongrad A; Chou CJ; Tartaglia LA; Lodish HF; Stahl A; Gimeno RE
Gastroenterology; 2006 Apr; 130(4):1259-69. PubMed ID: 16618417
[TBL] [Abstract][Full Text] [Related]
4. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ
J Lipid Res; 2011 Jun; 52(6):1084-1097. PubMed ID: 21398511
[TBL] [Abstract][Full Text] [Related]
5. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
Kumari A; Pal Pathak D; Asthana S
Int J Biol Sci; 2020; 16(13):2308-2322. PubMed ID: 32760200
[TBL] [Abstract][Full Text] [Related]
6. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
Chen Z; Fitzgerald RL; Averna MR; Schonfeld G
J Biol Chem; 2000 Oct; 275(42):32807-15. PubMed ID: 10893242
[TBL] [Abstract][Full Text] [Related]
7. Specific bile acids inhibit hepatic fatty acid uptake in mice.
Nie B; Park HM; Kazantzis M; Lin M; Henkin A; Ng S; Song S; Chen Y; Tran H; Lai R; Her C; Maher JJ; Forman BM; Stahl A
Hepatology; 2012 Oct; 56(4):1300-10. PubMed ID: 22531947
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis.
Conlon DM; Thomas T; Fedotova T; Hernandez-Ono A; Di Paolo G; Chan RB; Ruggles K; Gibeley S; Liu J; Ginsberg HN
J Clin Invest; 2016 Oct; 126(10):3852-3867. PubMed ID: 27599291
[TBL] [Abstract][Full Text] [Related]
9. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
[TBL] [Abstract][Full Text] [Related]
10. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
11. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase.
Miyake JH; Doung XD; Strauss W; Moore GL; Castellani LW; Curtiss LK; Taylor JM; Davis RA
J Biol Chem; 2001 Jun; 276(26):23304-11. PubMed ID: 11323427
[TBL] [Abstract][Full Text] [Related]
12. A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis.
Auinger A; Valenti L; Pfeuffer M; Helwig U; Herrmann J; Fracanzani AL; Dongiovanni P; Fargion S; Schrezenmeir J; Rubin D
Horm Metab Res; 2010 Nov; 42(12):854-9. PubMed ID: 20945272
[TBL] [Abstract][Full Text] [Related]
13. An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis.
Crooke RM; Graham MJ; Lemonidis KM; Whipple CP; Koo S; Perera RJ
J Lipid Res; 2005 May; 46(5):872-84. PubMed ID: 15716585
[TBL] [Abstract][Full Text] [Related]
14. Transcription profiling in the liver of undernourished male rat offspring reveals altered lipid metabolism pathways and predisposition to hepatic steatosis.
Lecoutre S; Montel V; Vallez E; Pourpe C; Delmont A; Eury E; Verbanck M; Dickes-Coopman A; Daubersies P; Lesage J; Laborie C; Tailleux A; Staels B; Froguel P; Breton C; Vieau D
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1094-E1107. PubMed ID: 31638854
[TBL] [Abstract][Full Text] [Related]
15. A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
Lin X; Chen Z; Yue P; Averna MR; Ostlund RE; Watson MA; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1170-6. PubMed ID: 16455790
[TBL] [Abstract][Full Text] [Related]
16. Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing.
Tep S; Mihaila R; Freeman A; Pickering V; Huynh F; Tadin-Strapps M; Stracks A; Hubbard B; Caldwell J; Flanagan WM; Kuklin NA; Ason B
J Lipid Res; 2012 May; 53(5):859-867. PubMed ID: 22355095
[TBL] [Abstract][Full Text] [Related]
17. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
Bell DA; Hooper AJ; Watts GF; Burnett JR
Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021
[TBL] [Abstract][Full Text] [Related]
18. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition.
Elam MB; von Wronski MA; Cagen L; Thorngate F; Kumar P; Heimberg M; Wilcox HG
Lipids; 1999 Aug; 34(8):809-16. PubMed ID: 10529091
[TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
